Lateral Epicondylitis
Conditions
Brief summary
The aim of this randomized controlled trial is to compare the effects of percutaneous electrolysis combined with exercise versus exercise alone on pain and function in patients with chronic lateral epicondylitis. Participants will be randomly allocated into two parallel groups. The control group will receive a 2-week exercise program including stretching and eccentric strengthening exercises for the wrist extensor and forearm muscles. The experimental group will receive the same exercise program plus three sessions of ultrasound-guided percutaneous electrolysis applied to the extensor carpi radialis brevis tendon insertion at the lateral epicondyle (on days 1, 8, and 14). Clinical outcomes will be assessed using a 10-cm Visual Analog Scale (VAS) for pain intensity, pressure pain threshold over the common extensor tendon measured with a handheld algometer, the Patient-Rated Tennis Elbow Evaluation (PRTEE) questionnaire for pain and functional disability, and the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire for upper limb function. Assessments will be performed at baseline, and then at 1 week, 1 month, and 3 months after the end of the 2-week treatment period. The study aims to determine whether adding percutaneous electrolysis to an exercise program provides greater improvement in pain and functional status than exercise alone in patients with chronic lateral epicondylitis.
Interventions
2-week exercise program with stretching and eccentric strengthening for wrist extensors and forearm muscles.
Participants receive the same 2-week exercise program as the control group plus three sessions of ultrasound-guided percutaneous electrolysis applied to the extensor carpi radialis brevis tendon insertion at the lateral epicondyle on days 1, 8, and 14.
Sponsors
Study design
Eligibility
Inclusion criteria
* Age between 18 and 65 years * Clinically and MRI-confirmed diagnosis of chronic lateral epicondylitis (symptoms ≥ 3 months) * Ability and willingness to comply with the treatment protocol and follow-up schedule
Exclusion criteria
* Previous elbow surgery or fracture in the affected limb * Local corticosteroid injection or other invasive treatment in the past 3 months * Cervical radiculopathy, systemic rheumatic disease, or other neurological disorders affecting the upper limb * Presence of a cardiac pacemaker or diagnosis of epilepsy * Pregnancy or breastfeeding * Serious bleeding disorder (coagulopathy) or current anticoagulant therapy * Inability to follow the exercise protocol or attend follow-up visits
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Pain Intensity (VAS) | Baseline, 1 week post-treatment, 1 month, 3 months | Pain intensity will be measured using a 10-cm Visual Analog Scale (VAS). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Pressure Pain Threshold (Algometry) | Baseline, 1 week post-treatment, 1 month, 3 months | Pressure pain threshold over the common extensor tendon will be measured using a handheld algometer. |
| Change in Functional Status (PRTEE Score) | Baseline, 1 week post-treatment, 1 month, 3 months | Functional disability and pain will be assessed using the Patient-Rated Tennis Elbow Evaluation (PRTEE). |
| Change in Upper Limb Function (QuickDASH) | Baseline, 1 week post-treatment, 1 month, 3 months | Upper limb disability will be evaluated using the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire. |
Countries
Turkey (Türkiye)